Table 2. HNSCC or control patient PB CD71 positivity (%) on T lymphocytes (CD3-positive cells) or monocyte 24 hours in vitro LPS-stimulated IL-6 secretion (pg/ml).
Control | HNSCC | p-value | |||||
---|---|---|---|---|---|---|---|
Mean | SD | Range | Mean | SD | Range | ||
Monocyte spontaneous in vitro 24-hour cytokine secretion | |||||||
IL-6 | 8210 | 13039 | 1–44747 | 3389 | 6409 | 0–26463 | n.s. |
Monocyte LPS-stimulated in vitro 24-hour cytokine secretion | |||||||
IL-6 | 51794 | 39837 | 7135–131011 | 51347 | 35653 | 1–139794 | n.s. |
Monocyte LPS-stimulated in vitro 24-hour net cytokine secretion | |||||||
IL-6 | 43588 | 34702 | 6857–127575 | 47835 | 33865 | 0–133014 | n.s. |
PB T lymphocytes CD71+ (%) | |||||||
CD71/CD3 | 8.3 | 4.6 | 1.0–8.3 | 9.2 | 6.0 | 1.6–25.4 | n.s. |